ClinicalTrials.Veeva

Menu

The Effects of Pelvic Floor Muscle Training Combined With Otago Exercises in Elderly People With Incontinence

C

Celal Bayar University

Status

Completed

Conditions

Pelvic Floor Muscle Weakness
Muscle Weakness
Urinary Incontinence

Treatments

Other: PFMT
Other: PFMT+Otago

Study type

Interventional

Funder types

Other

Identifiers

NCT06331039
CelalBayarU-5

Details and patient eligibility

About

Pelvic floor muscle weakness is one of the most important causes of incontinence. There are many studies supporting that pelvic floor muscle training prevents incontinence and reduces symptom severity, and with A level of evidence, it is among the first in the conservative treatment of incontinence. Functional status and balance problems are common in elderly people with incontinence, and it is known that functional type incontinence is common. Elderly people with incontinence most often fall while trying to get to the toilet. Balance exercises are recommended for falls and balance problems.

The aim of this study is to examine whether pelvic floor muscle training (PFMT) combined with Otago exercises is effective on symptoms, balance and functional status in elderly people with UI living in nursing homes, compared to PFMT alone.

Full description

The research was conducted on participants over the age of 65 with urinary incontinence living in a nursing home. After these participants were informed about the content of the study, a signed informed consent form will be obtained. This study is an assessor-blinded, randomized controlled trial. Participants with incontinence aged 65 and over living in a nursig home were randomly assigned to intervention (IG) and control group (CG). The intervention group attended an exercise program that included Otago exercises combined with pelvic floor muscle training (PFMT). The control group was included in the PFMT program with different positions. Duration of exercise for both groups was 45-60 minutes per session three times a week for 12 weeks. Incontinence symptoms and severity (Pelvic Floor Distress Inventory-20, bladder diary), PFM muscle function (superficial electromyography), balance (Berg Balance Scale), functional status (Senior Fitness Test) and fear of falling (Falls Efficacy Scale) was measured at baseline and after the intervention.

Enrollment

43 patients

Sex

All

Ages

65 to 100 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Having signed the informed volunteer consent form
  2. Being 65 years or older
  3. Having urinary incontinence
  4. Ability to walk unaided and not use any walking aids

Exclusion criteria

  1. Having severe walking and balance problems
  2. Severe cognitive impairment (Mini mental state assessment test score below 23)
  3. Having a serious neurological problem
  4. Having serious heart diseases
  5. Having a genito-urinary infection
  6. Having pelvic organ prolapse
  7. Six months ago he received medication for incontinence
  8. Having had incontinence and abdominal surgery
  9. Having metastatic cancer
  10. Having any vision problems

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

43 participants in 2 patient groups

PFMT+Balance Group
Experimental group
Description:
PFMT+Otago group was included in the program that includes Otago exercises and pelvic floor muscle training. Otago exercises combined with pelvic floor muscle training will be performed 3 days a week (with a 1-day rest gap between 2 sessions) for 45 minutes per day. Otago exercises consist of strengthening, balance exercises and walking program. Warm-up exercises were performed before each program and cooling exercises were performed at the end of the program. Exercises were performed for 45-60 minutes in each session.
Treatment:
Other: PFMT+Otago
PFMT Group
Experimental group
Description:
PFMT group was included in a program that includes pelvic floor muscle training, 3 days a week (with 1 day of rest between 2 sessions) and 45 minutes per day.
Treatment:
Other: PFMT

Trial contacts and locations

1

Loading...

Central trial contact

Özge ÇELİKER TOSUN, Assoc. Prof; Melda Başer Seçer, Phd

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems